Establishing an international baseline for medication safety in oncology: findings from the 2012 ISMP International Medication Safety Self Assessment for Oncology.
Greenall J, Shastay A, Vaida AJ, et al. J Oncol Pharm Pract. 2014 Oct 30; [Epub ahead of print].
In 2012, more than 350 organizations from 13 countries participated in the initial Institute for Safe Medication Practices self-assessment for oncology. This study describes results from this baseline survey, which revealed key opportunities for improvements in the safe delivery of chemotherapy. For example, many institutions have still not followed best practices for the administration of vincristine. In addition, less than half of respondents had fully implemented safety processes for oral chemotherapy orders. A prior AHRQ WebM&M commentary describes a patient who inadvertently received the wrong chemotherapy regimen and explores the high risks associated with inpatient chemotherapy.
With oral chemotherapy, we simply must do better!
ISMP Medication Safety Alert! Acute Care Edition. July 17, 2014;19:1-4.
Healthcare in a land called PeoplePower: nothing about me without me.
Delbanco T, Berwick DM, Boufford JI, et al. Health Expect. 2001;4:144-150.
Fluorouracil Incident Root Cause Analysis Report.
Toronto, ON, Canada: Institute for Safe Medication Practices Canada. May 8, 2007.
REVIEWView all related resources...
Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature.
Schwappach DLB, Wernli M. Eur J Cancer Care (Engl). 2009;19:285-292.
No hay comentarios:
Publicar un comentario